24/7 Wall St. on MSN
The pharmacy’s cash price for her generic will be $11. Her Part D plan will charge $47. Paying cash will save $36 but won’t count toward her $2,400 out-of-pocket cap
Quick ReadPaying cash for a generic saves money upfront but skips Part D tracking, so that spending never counts toward the ...
Utica Observer-Dispatch on MSN
NYS AG: Do you qualify for money back on generic drug prescriptions?
New York Attorney General Letitia James and a coalition of other AGs have reached some settlements in three lawsuits over alleged price inflation.
Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home.
The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...
Attorney General Gentner Drummond is urging Oklahomans to check their eligibility for generic drug settlement payments related to claims that certain generic dr ...
Generic drug manufacturers have greater protection from claims of induced infringement in “skinny label” cases following a unanimous 9-0 victory before the U.S. Supreme Court in Hikma Pharmaceuticals ...
FDA cleared generic rifapentine for active pulmonary TB (≥12 years) with susceptible isolates, requiring combination therapy with other active antitubercular agents. Authorization also covers LTBI (≥2 ...
A study found generic versions of certain MS treatments were linked to more variable disease biomarker profiles than ...
New Yorkers who purchased certain generic drugs may be eligible for compensation following settlements totaling more than $96 million with pharmaceutical companies accused of conspiring to inflate ...
Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...
Patent expirations, faster approvals and advanced manufacturing unlock opportunities in complex generics, biosimilars, oncology and cardiovascular therapiesDublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results